pharmacy benefit managers

Amazon, JPMorgan, Berkshire Hathaway collaboration puts insurers ‘on notice’Corporate giants Amazon, Berkshire Hathaway, and JPMorgan Chase, partner to shake things up in U.S. employee healthcare.
Four PBM programs poised to rein in the opioid epidemicPBMs are in a unique position to help curb opioid abuse. Here are four programs that demonstrate promising outcomes.
The New Goal for PBMs: Transparency
The New Goal for PBMs: TransparencyTraditional pharmacy benefit managers (PBMs) have come under fire for what some critics say is a lack of transparency. Opaqueness may be on the way out.
Controversy heats up over pharmacy benefit manager DIR feesPBMs make the argument for DIR fees after a litany of complaints from industry stakeholders.
Drug Spending Slows for Major Pharmacy Benefit Managers
Expedited FDA approval plays dominant role in drug approvalsLast year was a banner year for generic drug approvals by the FDA. Find out what’s in store for 2017.
Pharmacists Pushing for DIR Relief
Pharmacists Pushing for DIR ReliefCommunity pharmacists fight against financial pressure for their survival.
Health execs must brace for autoimmune drug changesA comprehensive understanding of this rapidly increasing drug class is essential to integrate pharmacy and medical claim information.
Walgreens-Prime alliance: A new breed pharmacy strategy?This model, touted as “next-generation,” combines retail and specialty and mail services and PBM along with immediate care clinics.
Top 4 pharmacy trends healthcare executives should watch
Top 4 pharmacy trends healthcare executives should watchManaged Healthcare Executive conducted its first-ever managed care pharmacy survey during the second quarter of 2016 in partnership with Access Market Intelligence. Here’s a look at some of the key findings, with experts weighing in on the results.